EP0506861A1 - Verfahren zur isolierung von galaktoseoxidase - Google Patents

Verfahren zur isolierung von galaktoseoxidase

Info

Publication number
EP0506861A1
EP0506861A1 EP91902619A EP91902619A EP0506861A1 EP 0506861 A1 EP0506861 A1 EP 0506861A1 EP 91902619 A EP91902619 A EP 91902619A EP 91902619 A EP91902619 A EP 91902619A EP 0506861 A1 EP0506861 A1 EP 0506861A1
Authority
EP
European Patent Office
Prior art keywords
process according
enzyme
solution
galactose oxidase
copper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP91902619A
Other languages
English (en)
French (fr)
Other versions
EP0506861A4 (en
Inventor
Laura Jane Crane
Adam Wieslaw Mazur
David Richard Nau
Bernard William Kluesener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of EP0506861A1 publication Critical patent/EP0506861A1/de
Publication of EP0506861A4 publication Critical patent/EP0506861A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)

Definitions

  • a method of isolating and purifying galactose oxidase from a fungus media is disclosed.
  • the supernatant liquid from a fermentation broth is subjected to ultrafiltration and then separated on a carboxy suifon cation exchange column using high pressure liquid chromatography. Copper ions must be present to insure enzyme activity.
  • Galactose oxidase (E.C. 1.1.3.9, GOase) is a copper-containing extracellular enzyme which oxidizes the primary hydroxyl groups of many alcohols and of galactose. Although the enzyme is produced by a number of fungus species, fermentation of Dactylium Dendroides is currently the best practical source. A simple method for the growth of this fungus and purification of the excreted enzyme from the growth medium is described by Tressel and Kosman, Analytical Biochemistry. 105. 150-153 (1930).
  • the enzyme is grown in a fungal culture aerobically in the dark for several days at 20 * C.
  • This fungus is then transferred to a glucose-based liquid medium and grown aerobically for about 2 days at 20 * C.
  • a completely artificial medium is used; it is a mixture of sorbose, glucose, traces of metal ions as micronutrients, and thiamine as the necessary vitamin. Growth of the culture takes usually 5 to 7 days.
  • Copper ion also preserves enzyme activity in unpurified fermentation medium by preventing complexation of galactose oxidase with an inhibitor (Avigad and Markus, Israel J. Chem.. 3, 193 (1966)). It is known that Dactylium Dendroides produces at least one galactose oxidase inhibitor identified as heptapeptide. This protein forms a stable inactive complex with galactose oxidase in the absence of copper. Presence of 1 to 10 mM cupric ion not only prevents this inhibition but also causes slow activation of the inhibited enzyme. The inhibiting components are usually removed from galactose oxidase preparations by chromatography.
  • the present process produces about a 45% yield of enzyme (measured as recovered activity) over a three day isolation period. It has now been found that this isolation and purification can be simplified and conducted on large quantities of enzyme preparation mixtures by the use of ultrafiltration and high pressure liquid chromatography purification techniques. Gram quantities of the galactose oxidase can be prepared in a day. Accordingly, it is an object of this invention to prepare large quantities of galactose oxidase in yields of above 70% (measured as recovered total activity) in an efficient manner. All percentages are by weight unless otherwise indicated.
  • a process for preparing and isolating pure galactose oxidase comprises the steps of
  • a starter broth of Dactylium Dendroides or other fungal source of galactose oxidase is prepared.
  • the procedure of Kosman, ibid involves preparation of stationary dextrose agar slants which are inoculated with Dactylium Dendroides.
  • the inoculated slants are grown aerobically in the dark for approximately two days at about 20*C to form a uniformly white, fluffy coating of fungus. Lengthy exposure to sunlight or an excessively warm incubation temperature results in "abnormal" cultures which are discolored and finely matted.
  • This starter fungus is mixed with a liquid medium to grow the galactose oxidase.
  • This completely artificial medium contains sorbose or glucose as the carbon sources, traces of metal ions as icronutrients and thia ine as the necessary vitamin. Growth in the culture takes 5 to 7 days. The pH of the growth media is neutral.
  • Copper sulfate increases the enzyme activity in the fermentation medium and improves reproducibility of the fermentation runs as compared to batches fermented by the standard method where the copper sulfate concentration was ll/zM.
  • the (Cu 2+) cupric concentration was increased to 1 mM, growth of ycelia was clearly retarded and only traces of galactose oxidase activity were detected.
  • the usual batch size for growing the Dactylium Dendroides is in 20 (L)liter containers. This process can easily be scaled up to grow the fungus in kiloliter containers.
  • Table 1 provides a flow chart for the preparation of the enzyme broth in 250L fer entor.
  • Trace metals which can be used in the fermentation broth include magnesium, manganese, zinc, calcium and iron. These metals are added as water soluble salts. Anions such as sulfate, chloride, nitrate and carbonate can be used.
  • the level of copper is very important and should be in the range of from about 10 to about 60 micromoles. Preferably, the amount of copper is from about 45 ⁇ m to about 58 ⁇ m.
  • the level of trace metals is generally equal to or less than the cupric level.
  • a source of nitrogen is required.
  • Ammonium nitrate is the preferred nitrogen source, but other inorganic salts can be used, for example, sodium or potassium nitrate, ammonium sulfate, ammonium hydrogen phosphate, am onium phosphate, etc. Any alkali metal or alkaline earth metal nitrate can be used. Urea can also be used as a nitrogen source.
  • the carbon source is preferably glucose or sorbose, but other low molecular weight carbohydrates can be used. These include fructose, sucrose and mannose.
  • the level of carbohydrate is from about 0.2% to about 10% in the fermentation broth.
  • Thiamine is added at about 1 to about 10 micromoles.
  • the pH of the medium is held at about 6.0 to about 7.8.
  • the pH is preferably controlled through the use of phosphate buffers, but other buffers can be used.
  • the temperature of the fermentation is maintained at ambient temperature and preferably between 20°C and 25°C. If necessary, the level of water is maintained by replacing water lost to evaporation.
  • the solution is stirred and aerated with a flow of air. Compressed air which has been filtered to remove any oil or other contaminants is used.
  • the air can be passed through an oil filter and a glass wool plug to remove most of the contaminants.
  • the air flow is adjusted to a rate which maintains the desired degree of oxygen saturation in the broth.
  • atmospheric oxygen at above
  • the broth is about
  • the usual length of time that the fermentation is carried out is from about 100 to about 200 hours, preferably from about 120 to about 145 hours.
  • SUBSTITUTE SHEET B Isolation of the Galactose Oxidase Table 2 illustrates the isolation process.
  • the contents of the fermentation batches are cooled to about 3° to about 10°C and filtered through a 0.15 to 0.25 ⁇ m filter.
  • Conventional filters such as millipore or other filters are acceptable.
  • Use of a millipore filter is a preferable filtration technique because it also removes gel-like polymers which can foul the membrane of the ultrafiltration apparatus in the next step.
  • other means of filtration such as nylon mesh sheet CMN-210 (Small Points, Florida) can also be used.
  • Copper sulfate and histidine are added to the filtrate in the amount necessary to make a 8mM to about a 12 mM solution of copper ion (cupric) and about 15 mM to about 25 mM of histidine.
  • the filtrate is concentrated to about 10% to about 25% by ultrafiltration through a 10,000 molecular weight cut off membrane: Millipore Pellicon Cassette System can be used j as can other ultrafiltration systems.
  • the retentate is optionally equilibrated with a freshly prepared buffer (pH about 7.0) containing copper sulfate (3-8 mM), histidine (3-8mM) and sodium hydroxide (3-8mM). Again the solution is concentrated to about equal volumes as before.
  • the retentate is optionally treated with DEAE cellulose which has been equilibrated with a phosphate buffer (pH about 7.0) containing copper sulfate and histidine.
  • a phosphate buffer pH about 7.0
  • the cellulose adsorbs about 50% of the contaminating proteins from the retentate, i.e. the galactose oxidase containing solution. Removal of these proteins facilitates the final purification of the enzymes.
  • the cellulose is filtered and, if cloudy, centrifuged to remove any materials. A 5 minute to about 30 minute cellulose treatment is usually sufficient to remove these proteins.
  • This solution is again subjected to ultrafiltration to further concentrate it to about 10% to about 25% of the starting solution.
  • the enzyme is equilibrated during this concentration
  • the enzyme solution is finally purified using high performance liquid chromatography (HPLC).
  • HPLC high performance liquid chromatography
  • a carboxy-sulfon 40 micron column from J. T. Baker is used (Bakerbond Carboxy- sulfon ® ).
  • the carboxy-sulfon columns can contain particles ranging from 5 microns to 50 microns in size.
  • the carboxy-sulfon substrate is described in U.S. 4,721,573 which is incorporated by reference herein.
  • a linear gradient is applied of a buffer containing sodium acetate, histidine and cupric sulfate. Usually this elution is done over about 1 to 2 hours with a flow rate of about 0.5 ml/min. to about 2 ml/min.
  • a step gradient of about 10% to about 15% is generally used.
  • the exact concentration gradients and times will depend on the solution and the column length as well as the method of loading the column. One skilled in the art will be able to determine the exact method with minimal experimentation.
  • the enzyme position is determined using a ultraviolet light at 280 nm.
  • An assay solution is prepared by. boiling a phosphate buffer (0.1M, pH 7.0) and then cooling it to a room temperature. To this buffer is added 500 mg of D-galactose (available from Sigma as a "substantially glucose free” material), 5 mg horseradish peroxidase, (available from Sigma, type III mixture of basic isozy es) and 5 mg o-dianisidine (3, 3'-dimethoxybenzidine), dissolved in 0.5 ml of ethanol . These solutions are added to the phosphate buffer and the buffer is diluted to 100 ml in a volumetric flask. O-Dianisidine (3-3'-dimethoxybenzidine) should be added quickly otherwise a cloudy suspension will result. The assay solution must be stored away from the light and be refrigerated. The solution should be discarded when the absorbance at 460 nm becomes greater than 0.1 than the buffer solution alone.
  • D-galactose available from Sigma as a "substantially glucose free” material
  • the activity of the glactose oxidase To assay the activity of the glactose oxidase, one ml of the assay solution is added at room temperature to a microcuvette for an ultraviolet spectrometer. A sample of the enzyme (5 to 50 micro!iters) is injected into the assay solution and stired for about a second. The linear absorbance increase is followed for one minute and the absorbance/per minute is calculated. The amount of enzyme added should be adjusted until this value is between 0.2 and 0.6.
  • the solid sample When using solid enzyme samples, the solid sample is dissolved in 0.1 M phosphate buffer (pH 7.0) to make the amount of enzyme equal to approximately 0.4 units in the assay mixture.
  • Protein Assay Bio-Rad protein assay dye concentrate catalogue number 500-006 is used for an assay standard. This protein assay dye should be diluted to a concentration of about one (1) volume of concentrate to four (4) volumes of distilled water.
  • a solution of bovine serum albumin in 0.15 M sodium chloride is prepared (1 mg per ml).
  • Ten samples containing from 10 to 100 micrograms of the protein are added to test tubes (10 micro!iter, 20 micro!iter, etc.) The volume in each test tube is adjusted to 0.1 milliliter.
  • Dactylium Dendroides strain NRRL 2903 was obtained from Dr. 0. J. Ellis of the USDA of the Northern Regional Research Laboratory (Pioria, IL.) and was maintained on agar slants.
  • a 20 liter autoclaveable plastic bottle was equipped with four metal aerators and a three stage turbine propeller for mixing. Compressed air was filtered through an oil removal filter (DPS-19 from Grainview Products, California) followed by sterile glass wool filters. After passing through the filters, the air is distributed through the four aerators in the bottle. During the fermentation, the total air flow in each bottle (fermentation flask) is maintained at 19 liters/minute as measured at the outlet of the air.
  • Solution A (salts, nitrogen) 10.74 g/1 32HP04 10.41 g/1 KH2PO4 1.27 g/1 (NH4) 2 N0 3 2.50 g/1 ( H4)2S ⁇ 4 0.93 g/1 NaOH 1.07 g/1 K0H Solution B: (trace metals) 2.05 g/1 MgS04 19.48 mg/1 nS04 • H2O 30.00 mg/1 ZnS047 • H2O 17.75 mg/1 CaCl22 • H2O 28.44 mg/1 FeS07 • H2O 135 mg/1 CUSO45 • H2O
  • Solution C (carbon source) for agar slants and starter flasks: 79.4 g/1 glucose
  • the fermentation flasks are maintained at 21° C in water baths. Temperature control is provided by circulating water in the tubing of the cooling or heating medium by a thermostat.
  • Solution A is placed in the fermentation flask. Stirrers and aerators are then inserted into the flask and a slow flow of air is turned on. Stirring rate is maintained at 490 RPM (gentle stirring). Solutions B and C are added to each flask followed by the addition of a thiamine stock solution (800 microliters). The fermentators are then innoculated with 120 ml of the mycelia suspension from the starter flask. The air flow is adjusted from 19 liters/minute and the fermentation was allowed to continue from 136 to 140 hours.
  • the solution is fed into the cartridge from a pressurized container.
  • the fine filtration is necessary to remove a gel-like polymer.
  • Two cartridges are used, one for each 15 liters of the solution.
  • the filtered solution is concentration to about 500 ml by ultrafiltration using a millipore Pellicon cassette system equipped with a 10,000 MWCO membrane cassette. This concentration takes from 1-2 hours for the 30 liter solution.
  • the retentate is equilibrated on the same millipore Pellicon cassette system with a freshly prepared buffer containing copper sulfate, (5 milli oles), histidine (5 milli oles) and sodium hydroxide (5 millimoles), a pH of about 5.6
  • the retentate is treated with DEAE cellulose (60 grams) equilibrated with the same buffer as was used in the ultrafiltration system and stirred for 15 minutes.
  • the cellulose is removed by suction filtration.
  • the filtrate is centrifuged at
  • the clear enzyme solution is concentrated to about 15 ml using an Amicon stirred ultrafiltration cell equipped with 10,000 MWCO membrane (PM-10 diameter 76 mm) at 40 psi. This ultrafiltration takes 3-6 hours.
  • the concentrated enzyme solution is equilibrated with a solution of copper sulfate (2 millimoles), histidine (4 millimoles), and MES (20 millimoles) at a pH of 5.6 using a dialysis bag fitted with a 10,000 MWCO membrane size.
  • the retentate is centrifuged at 9,000 g for 30 minutes to remove any cloudiness.
  • the concentrate is filtered through a plug of G/F Whatman gl ass fiber fil ter to remove fine particles from this sol ution .
  • a high pressure liquid chromatography column (40 microns) is filled with carboxy sulfone (J. T. Baker, Bakerbond carboxy- suifon ®) (40.6 X 250 mm).
  • the concentrated enzyme solution (1.75 ml) is loaded onto the column using a 2 ml loop.
  • the void volume peak is eluted and collected.
  • Four to five portions of the concentrated crude enzyme are injected onto the column and the void volumes eluted. After the last void volume is eluted, a linear gradient from 100% A to 100% B over a one hour period is applied.
  • the flow rate is 1 ml per minute.
  • Buffer A is a mixture of 20 mM 2-N morpholino ethane sulfonic acid (MES), 2 millimolar copper sulfate, 4 millimolar histidine at a pH of 5.6 adjusted with sodium hydroxide.
  • Buffer B is a 1 molar solution of sodium acetate, 2 millimolar copper sulfate, 4 millimolar histidine at a pH of 5.8 adjusted with acetic acid or sodium hydroxide.
  • the galactose oxidase enzyme elutes in about 16 minutes.
  • An ultraviolet detector set at 280 nm can be used to detect the enzyme. " . Void volumes are analyzed for the presence of galactose oxidase by standard activity analysis. If enzyme is present, the void solution can be rechromatographed after concentration by ultrafiltration) in the presence of copper ions and histidine. A yield of 70% galactose oxidase is obtained.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP19910902619 1989-12-20 1990-11-19 Process for isolating galactose oxidase Withdrawn EP0506861A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45372989A 1989-12-20 1989-12-20
US453729 1999-12-02

Publications (2)

Publication Number Publication Date
EP0506861A1 true EP0506861A1 (de) 1992-10-07
EP0506861A4 EP0506861A4 (en) 1993-02-17

Family

ID=23801821

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910902619 Withdrawn EP0506861A4 (en) 1989-12-20 1990-11-19 Process for isolating galactose oxidase

Country Status (5)

Country Link
EP (1) EP0506861A4 (de)
JP (1) JPH05503012A (de)
AU (1) AU7170691A (de)
CA (1) CA2069629C (de)
WO (1) WO1991009117A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW409035B (en) 1997-06-04 2000-10-21 Gist Brocades Bv Starch-based enzyme granulates

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025424A1 (de) * 1979-07-05 1981-01-15 Kyowa Hakko Kogyo Kk Verfahren zur herstellung von galactoseoxidase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661248A (en) * 1986-03-06 1987-04-28 J. T. Baker Chemical Company Sulfonic derivatives of acylated polyethyleneimine bonded phase silica products
US4721573A (en) * 1986-03-06 1988-01-26 J. T. Baker Chemical Company Use of sulfonic derivatives of acylated polyethyleneimine bonded phase silica products

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025424A1 (de) * 1979-07-05 1981-01-15 Kyowa Hakko Kogyo Kk Verfahren zur herstellung von galactoseoxidase

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AGRICULTURAL AND BIOLOGICAL CHEMISTRY. vol. 46, no. 5, May 1982, TOKYO JP pages 1191 - 1197 KAZUO AISAKA ET AL. 'Purification and properties of galactose oxidase from Gibberella fujikuroi' *
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS vol. 263, no. 2, June 1988, pages 349 - 354 FRANCES M. KELLEHER ET AL. 'Purification of galactose oxidase from Dactylium dendroides by affinity chromatography on melibiose-polyacrilamide' *
See also references of WO9109117A1 *

Also Published As

Publication number Publication date
EP0506861A4 (en) 1993-02-17
CA2069629A1 (en) 1991-06-21
JPH05503012A (ja) 1993-05-27
AU7170691A (en) 1991-07-18
WO1991009117A1 (en) 1991-06-27
CA2069629C (en) 1995-08-29

Similar Documents

Publication Publication Date Title
Bakoyianis et al. Low-temperature wine making by immobilized cells on mineral kissiris
US4450153A (en) Alcohol removal from blood with alcohol oxidase
Mirsky et al. Chromium in biological systems, I. Some observations on glucose tolerance factor in yeast
CA1236415A (en) Process for the biotechnological preparation of poly- d-(-)-3-hydroxybutyric acid
Roitner et al. Charakterisierung von Naringinase aus Aspergillus niger
FI58513C (fi) Foerfarande foer framstaellning av ett stabilt glukosisomerasenzymkoncentrat
EP0054066B1 (de) Verfahren zur herstellung von glucoson
US4321323A (en) Carbohydrate process
US4540668A (en) Alcohol oxidase from Pichia-type yeasts
EP0019937B1 (de) Verfahren zur Herstellung von Alkoholoxidase, Alkoholoxidase, Enzymzubereitung und Verfahren zur Konzentrationsbestimmung einer Verbindung in einer Alkohol enthaltenden Probe
US5149646A (en) Process for isolating galactose oxidase
Srere et al. Citrate lyase: a pantothenate-containing enzyme
CA1226836A (en) 2,5-diketo-d-gluconic acid reductase
US4569913A (en) P. obtusus pyranose-2-oxidase preparation
EP0506861A1 (de) Verfahren zur isolierung von galaktoseoxidase
Adachi et al. Conversion of quinate to 3-dehydroshikimate by Ca-alginate-immobilized membrane of Gluconobacter oxydans IFO 3244 and subsequent asymmetric reduction of 3-dehydroshikimate to shikimate by immobilized cytoplasmic NADP-shikimate dehydrogenase
US4062731A (en) Production of uricase from micrococcus luteus
EP0219673B1 (de) Verfahren zur Herstellung einer thermostabilen Transglucosidase
US4569915A (en) P. obtusus strain
US4569910A (en) Methods and reagents for pyranosone production
US5250305A (en) Process for enzymatic ultrafiltration of deamidated protein
JPS63216493A (ja) 高純度イソマルト−スの製造方法
US4568645A (en) Fungal pyranose-2-oxidase preparations
EP0281143B1 (de) Verfahren zur Herstellung von mevalonischer Säure
EP0618963B1 (de) Verfahren zur herstellung von neuraminidase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19921230

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19941216

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19950223